MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, TYRA has $412,040K in assets. $24,465K in debts. $84,955K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2049.30%
Quick Ratio
2049.30%
Cash Ratio
441.19%
Debt to Asset Ratio
5.94%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Other long-term assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Lease liabilities, noncurrent
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
84,955 77,387 61,951 98,490
Marketable securities
298,511 178,616 212,973 197,781
Prepaid expenses and other current assets
11,147 9,447 6,292 5,884
Total current assets
394,613 265,450 281,216 302,155
Restricted cash
884 1,000 1,000 1,000
Property and equipment, net
1,215 1,314 1,346 1,413
Right-of-use asset
5,443 5,573 5,699 5,822
Other long-term assets
9,885 9,272 12,590 11,109
Total assets
412,040 282,609 301,851 321,499
Accounts payable
3,642 1,178 1,991 2,245
Lease liabilities, current
488 472 456 441
Accrued expenses and other current liabilities
15,126 16,444 13,432 11,084
Total current liabilities
19,256 18,094 15,879 13,770
Other long-term liabilities
-0 0 0
Lease liabilities, noncurrent
5,209 5,338 5,463 5,582
Total liabilities
24,465 23,432 21,342 19,352
Common stock, 0.0001 par value 500,000,000 shares authorized at march 31, 2026 and december 31, 2025 53,706,357 and 50,754,262 shares issued at march 31, 2026 and december 31, 2025, respectively, and 53,706,357 and 50,749,945 shares outstanding at march 31, 2026 and december 31, 2025, respectively
6 5 5 5
Additional paid-in capital
798,025 630,037 617,486 609,262
Accumulated other comprehensive income
107 393 442 436
Accumulated deficit
-410,563 -371,258 -337,424 -307,556
Total stockholders' equity
387,575 259,177 280,509 302,147
Total liabilities and stockholders' equity
412,040 282,609 301,851 321,499
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$298,511K Cash and cashequivalents$84,955K Prepaid expenses andother current assets$11,147K Total current assets$394,613K Other long-termassets$9,885K Right-of-use asset$5,443K Property and equipment,net$1,215K Restricted cash$884K Total assets$412,040K Total liabilities andstockholders' equity$412,040K Total stockholders'equity$387,575K Total liabilities$24,465K Accumulated deficit-$410,563K Additional paid-in capital$798,025K Total currentliabilities$19,256K Lease liabilities,noncurrent$5,209K Accumulated othercomprehensive income$107K Common stock, 0.0001par value...$6K Accrued expenses andother current...$15,126K Accounts payable$3,642K Lease liabilities,current$488K

Tyra Biosciences, Inc. (TYRA)

Tyra Biosciences, Inc. (TYRA)